Athletes with Implantable Cardioverter-Defibrillators: A Practical Framework for Device Selection, Programming, and Return-to-Sport Risk Mitigation
Open Access
- 13 September 2026
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7103
Abstract
Implantable cardioverter-defibrillators (ICDs) were historically viewed as a barrier to vigorous or competitive sport participation, based on theoretical concerns about arrhythmia induction, inappropriate shocks, device damage, and shock-related injury during activity. Contemporary registry data have reframed this paradigm, demonstrating that selected athletes with ICDs can participate in organized sport without the catastrophic outcomes once feared, although these data remain reassuring rather than definitive given selection bias and underrepresentation of high-consequence sports. This review synthesizes contemporary athlete-specific registry data and broader randomized device and programming evidence, alongside current guideline recommendations, to provide a practical framework for the care of athletes with ICDs, addressing indications, which should remain diagnosis-driven rather than sport-driven; device selection, weighing transvenous, subcutaneous, and extravascular platforms against an athlete’s pacing needs, anatomy, and sport-specific trauma risk; and exercise-informed device programming. We then present a longitudinal framework integrating clinical readiness, device readiness, sport-specific risk, emergency preparedness, shared decision-making, and reassessment after clinical or sporting changes. Special populations and priorities for future research are also discussed. Rather than a binary clearance decision, modern management of athletes with ICDs requires an individualized, longitudinally reassessed approach to risk.Keywords
This publication has 37 references indexed in Scilit:
- Safety of Sports for Athletes With Implantable Cardioverter-DefibrillatorsCirculation, 2017
- 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testingHeart Rhythm, 2016
- Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General ConsiderationsJACC, 2015
- Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction DefectsJACC, 2015
- Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary resultsHeart Rhythm, 2015
- Safety of Sports for Athletes With Implantable Cardioverter-DefibrillatorsCirculation, 2013
- Effect of Long-Detection Interval vs Standard-Detection Interval for Implantable Cardioverter-Defibrillators on Antitachycardia Pacing and Shock DeliveryJAMA, 2013
- Reduction in Inappropriate Therapy and Mortality through ICD ProgrammingNew England Journal of Medicine, 2012
- Inter-association Task Force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement.2007
- Introduction: Eligibility recommendations for competitive athletes with cardiovascular abnormalities—general considerationsJACC, 2005